Pharma & Life Sciences

Bridging Science, Innovation and Manufacturing in Bioprocessing and Biopharma

MSS2026 is a hybrid symposium focusing on production solutions and advanced analytics for gene therapies, vaccines, and complex biological products. It covers the entire bioprocessing workflow from development to manufacturing, including upstream and downstream processing. The event is intended for professionals in bioprocessing and biopharma.

6 weeks until it opens.

The essentials

Event details

Dates
14 September 2026 to 16 September 2026
Organiser
MSS
Industry
Pharma & Life Sciences

Agenda themes

Topics covered

  • Medical & Pharma

On stage

Speakers

  • Dan Peer, Laboratory of Precision Nanomedicine, Tel Aviv University
  • Andre Germishuizen, National Bioproducts Institute (NBI)
  • Jacek Lubelski, NanoCell, tLNP
  • Aleš Štrancar, BIA Separations Inc
  • Manuela Bartolini, Alma Mater Studiorum University of Bologna
  • Stefano Menegatti, North Carolina State University
  • Thomas Muster, BlueSky Immunotherapies

On the floor

Sponsors and partners

  • TAGCyx Biotechnologies Inc
  • Infinite d.o.o
  • Katezai Engineering
  • A-SpecTar GmbH
  • BIA Separations, Inc
  • Ablevia
  • Phoenestra
  • NibaLabs
  • Sferogen
  • Purify Handels
  • Gene Therapy Net
  • Drug Discovery & Development
  • Info360

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.